Modeling congenital cataract in vitro using patient-specific induced pluripotent stem cells

Area of Science:

• Ophthalmology
• Stem Cell Biology
• Genetics

Background:

• Congenital cataracts are a primary cause of childhood blindness, with surgery being the only treatment but carrying risks.
• Current research into novel therapeutic strategies is limited by the absence of suitable human congenital cataract models.
• Developing effective treatments necessitates better understanding of disease mechanisms and efficient drug candidate screening.

Purpose of the Study:

• To establish a human congenital cataract in vitro model using patient-specific induced pluripotent stem cells (iPSCs).
• To validate the model's ability to recapitulate key features of congenital cataracts, including opacification and protein aggregation.
• To assess the utility of the model for studying cataract pathology and screening potential therapeutic compounds.

Main Methods:

• Generation of patient-specific iPSCs from individuals with known congenital cataract mutations (CRYBB2 [p. P24T] and CRYGD [p. Q155X]).
• Differentiation of iPSCs into regenerated lenses (lentoid bodies - LBs) in vitro.
• Comparative analysis of opacification, protein aggregation, and solubility between patient-derived and healthy control LBs.
• Evaluation of lanosterol treatment effects on protein aggregation in patient-derived LBs.

Main Results:

• Patient-specific iPSC-derived lenses exhibited opacification mirroring clinical congenital cataracts.
• Increased protein aggregation and reduced protein solubility were observed in patient-derived LBs, correlating with cataract severity.
• Lanosterol treatment demonstrated an ability to attenuate protein aggregation in the patient-specific LBs.
• The in vitro model successfully recapitulated patient-specific clinical manifestations and pathological features.

Conclusions:

• A robust human congenital cataract in vitro model has been successfully established using patient-specific iPSCs.
• This model accurately replicates key pathological features, including lens opacification and protein aggregation.
• The model serves as a valuable platform for investigating congenital cataract mechanisms and for screening novel drug candidates for therapeutic intervention.